Xu, Ying
Li, Zhuo
Zhi, Weihua
Yang, Yi
Ouyang, Jingzhong
Zhou, Yanzhao
Ma, Zeliang
Wang, Sicong
Xie, Lizhi
Ying, Jianming
Zhou, Jinxue
Zhao, Xinming
Funding for this research was provided by:
CAMS Innovation Fund for Medical Sciences (2022-I2M-C&T-B-081, 2021-I2M-C&T-B-057)
Article History
Received: 10 June 2024
Accepted: 26 May 2025
First Online: 30 August 2025
Declarations
:
: All centres complied with local ethics requirements. Research procedures were conducted in accordance with the Declaration of Helsinki (1975) and its amendments. The study was approved by the Institutional Research Ethics Committee of Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College and Affiliated Cancer Hospital of Zhengzhou University. This study was conducted and reported the data according to STROBE guidelines. The manuscript is in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aims for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The authors declare that this report does not contain any personal information that could lead to identification.
: The requirement for written informed consent was waived by the Institutional Research Ethics Committee of Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College and Affiliated Cancer Hospital of Zhengzhou University because of the retrospective nature of the study.
: S.W. and L.X. are affiliated with GE Healthcare. The remaining authors declared no potential competing interest with respect to the research, authorship, and/or publication of this article.